National Trends in the US Public’s Likelihood of Getting a COVID-19 Vaccine—April 1 to December 8, 2020

Szilâgyi, Peter G.; Thomas, Kyla; Shah, Megha D.; Vizueta, Nathalie; Cui, Yan; Vangala, Sitaram; Kapteyn, Arie

doi:10.1001/jama.2020.26419

Cited by 258 publications

(333 citation statements)

References 4 publications

Supporting

Mentioning

272

Contrasting

Unclassified

Order By: Relevance

“…Regarding participants' likelihood of getting a COVID-19 vaccine, if a participant responded "very likely" or "somewhat likely", it was determined that the participant had a high likelihood of getting a COVID-19 vaccine [18]. We clarified the proportion of participants with a high likelihood of getting a COVID-19 vaccine.…”

Section: Discussionmentioning

confidence: 99%

“…In order to plan adequate COVID-19 vaccine uptake among the general public, understanding the public's concerns regarding the COVID-19 vaccine is essential [12,13]. As with previous studies on vaccine hesitancy for vaccines [13], studies on COVID-19 vaccine acceptance have demonstrated that the acceptability of the vaccine differs depending on sociodemographic factors, such as race and educational level, as well as attitudes and beliefs regarding COVID-19 infection and vaccination [14][15][16][17][18][19]. A global survey, which included 19 countries, also reported that responses in different countries show that COVID-19 vaccine acceptance has high heterogeneity [20]; therefore, it is important to clarify the acceptance of a vaccine in each country or region.…”

Section: Introductionmentioning

confidence: 94%

“…We asked the participants to indicate how likely they were to get vaccinated for COVID-19, once a vaccine is available to the public. With reference to a previous study, five response options were provided: very unlikely, somewhat unlikely, somewhat likely, very likely, and unsure [18].…”

Section: Assessment Of Participants' Likelihood Of Getting a Covid-19mentioning

confidence: 99%

See 2 more Smart Citations

Acceptance of a COVID-19 Vaccine in Japan during the COVID-19 Pandemic

et al. 2021

View full text Add to dashboard Cite

Vaccination could be a key protective measure against coronavirus disease 2019 (COVID-19), and it is important to understand the acceptability of the COVID-19 vaccine among the general public. However, there is no study on the acceptance of a COVID-19 vaccine in Japan. Therefore, this study aimed to describe the COVID-19 vaccine acceptance and hesitancy situation in Japan and assess the factors associated with such issues. This was a cross-sectional study based on an internet survey completed by 2956 people. Participants were asked to indicate how likely they were to get vaccinated for COVID-19. In addition, the participants responded to questions regarding sociodemographic factors, attitudes, and beliefs regarding COVID-19 infection and vaccination. The proportion of participants with a high likelihood of getting a COVID-19 vaccine was 62.1%. Multiple logistic regression analysis showed that vaccine acceptance was lower among several sociodemographic groups, such as women, adults aged 20–49 years, and those with a low-income level. Several psychological factors, especially the perceived effectiveness of the COVID-19 vaccine, and willingness to protect others by getting oneself vaccinated, were associated with vaccine acceptance. Our results indicate that the perceived effectiveness of the vaccine and willingness to protect others may play an important role in the acceptance of the COVID-19 vaccine.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 94%

See 1 more Smart Citation

Acceptance of a COVID-19 Vaccine in Japan during the COVID-19 Pandemic

et al. 2021

View full text Add to dashboard Cite

show abstract

“…Younger adults, women, Black persons, adults living in nonmetropolitan areas, and adults with lower educational attainment, with lower income, and without insurance were most likely to report that they did not intend to receive COVID-19 vaccination. Several studies found similar percentages and trends in vaccination intent and low likelihood of receiving a COVID-19 vaccine among groups disproportionately affected by COVID-19, including Black persons and those with lower educational attainment (6,7). Because many of these groups are at increased risk for COVID-19-associated morbidity and mortality (8), COVID-19 vaccination is important for protecting the health of these populations and reducing health inequities.…”

Section: Discussionmentioning

confidence: 99%

COVID-19 Vaccination Intent, Perceptions, and Reasons for Not Vaccinating Among Groups Prioritized for Early Vaccination — United States, September and December 2020

Nguyen¹,

Srivastav²,

Razzaghi³

et al. 2021

MMWR Morb. Mortal. Wkly. Rep.

213

173

View full text Add to dashboard Cite

On February 9, 2021, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr). As of February 8, 2021, 59.3 million doses of vaccines to prevent coronavirus disease 2019 (COVID-19) had been distributed in the United States, and 31.6 million persons had received at least 1 dose of the COVID-19 vaccine (1). However, national polls conducted before vaccine distribution began suggested that many persons were hesitant to receive COVID-19 vaccination (2). To examine perceptions toward COVID-19 vaccine and intentions to be vaccinated, in September and December 2020, CDC conducted household panel surveys among a representative sample of U.S. adults. From September to December, vaccination intent (defined as being absolutely certain or very likely to be vaccinated) increased overall (from 39.4% to 49.1%); the largest increase occurred among adults aged ≥65 years. If defined as being absolutely certain, very likely, or somewhat likely to be vaccinated, vaccination intent increased overall from September (61.9%) to December (68.0%). Vaccination nonintent (defined as not intending to receive a COVID-19 vaccination) decreased among all adults (from 38.1% to 32.1%) and among most sociodemographic groups. Younger adults, women, non-Hispanic Black (Black) persons, adults living in nonmetropolitan areas, and adults with lower educational attainment, with lower income, and without health insurance were most likely to report lack of intent to receive COVID-19 vaccine. Intent to receive COVID-19 vaccine increased among adults aged ≥65 years by 17.1 percentage points (from 49.1% to 66.2%), among essential workers by 8.8 points (from 37.1% to 45.9%), and among adults aged 18-64 years with underlying medical conditions by 5.3 points (from 36.5% to 41.8%). Although confidence in COVID-19 vaccines increased during September-December 2020 in the United States, additional efforts to tailor messages and implement strategies to further increase the public's confidence, overall and within specific subpopulations, are needed. Ensuring high and equitable vaccination coverage across all populations is important to prevent the spread of COVID-19 and mitigate the impact of the pandemic. The Advisory Committee on Immunization Practices (ACIP) has issued interim recommendations for COVID-19 vaccine allocation, with initial limited supplies of vaccines recommended for health care personnel and residents of long-term care facilities (phase 1a); frontline essential workers and persons aged ≥75 years (phase 1b); and persons aged 65-74 years, persons aged 16-64 years at high risk for severe COVID-19 illness because of underlying medical conditions,* and other workers in essential and critical infrastructure sectors † not included in phases 1a and 1b (phase 1c) (3,4). Vaccinating a large proportion of persons in the United States against COVID-19 is critical for preventing SARS-CoV-2associated morbidity and mortality and helping bring an end to the global pandemic. During September 3-October 1, CDC conducted a probabi...

show abstract

“…Moreover, recent surveys have shown over the time a reduction of the acceptance, probably linked to the infodemic and decreasing trust in information from the media -often contradictory -and in governmental communication. In a US longitudinal panel survey, self-reported likelihood of getting a COVID-19 vaccine declined from 74% in April to 56% in December 2020, despite the press releases of high vaccine efficacy for two mRNA vaccines, prior to Emergency Use Authorization granted from the FDA [9].…”

Section: Discussionmentioning

confidence: 99%

Italian Adults’ Likelihood of Getting COVID-19 Vaccine: A Second Online Survey

Biasio¹,

Bonaccorsi

Lorini

et al. 2021

Preprint

View full text Add to dashboard Cite

Rapid online surveys are an important tool in tracking the public’s knowledge and perceptions during infectious disease outbreaks. In June 2020, during the early phases of COVID-19 vaccines development, a survey had been conducted, aimed at assessing attitudes and opinions about vaccination of 885 Italian adults, in addition to their vaccine literacy levels (i.e. skills of finding, understanding and using information about vaccines). In January 2021, the same questionnaire has been administered to a similar population (n=160). Interactive vaccine literacy was significantly higher than in June 2020 (mean score 3.38 vs 3.27 respectively, P=.0021). The percentage of participants willing to be vaccinated against COVID-19 was assessed by the means of either-or questions, and was equally high in both surveys (>90%), which is quite reassuring, despite metrics based on categorical scales cannot identify hesitant subjects.

show abstract

National Trends in the US Public’s Likelihood of Getting a COVID-19 Vaccine—April 1 to December 8, 2020

Cited by 258 publications

References 4 publications

Acceptance of a COVID-19 Vaccine in Japan during the COVID-19 Pandemic

Acceptance of a COVID-19 Vaccine in Japan during the COVID-19 Pandemic

COVID-19 Vaccination Intent, Perceptions, and Reasons for Not Vaccinating Among Groups Prioritized for Early Vaccination — United States, September and December 2020

Italian Adults’ Likelihood of Getting COVID-19 Vaccine: A Second Online Survey

Contact Info

Product

Resources

About